Literature DB >> 20108377

Psychiatric disorders in adult-onset focal dystonia: a case-control study.

Giovanni Fabbrini1, Isabella Berardelli, Germana Moretti, Massimo Pasquini, Maria Bloise, Carlo Colosimo, Massimo Biondi, Alfredo Berardelli.   

Abstract

In a single-center, case-control study, we investigated the frequency and types of psychiatric disturbances in 89 consecutive patients with various primary focal dystonias (34 had cervical dystonia (CD), 28 blepharospasm (BPS), 16 laryngeal dystonia (LD), and 11 arm dystonia), 62 healthy control subjects and as controls for BPS, 26 patients with hemifacial spasm (HFS). Patients and controls underwent a full psychiatric evaluation. Diagnosis was based on the structured clinical interview for DSM-IV, obsessive-compulsive disorder (OCD) was assessed with the Yale-Brown Obsessive-Compulsive scale, anxiety with the Hamilton Rating Scale for Anxiety, the severity of depression with the Beck Depression Inventory. Of the 89 patients with focal dystonias studied, 51 patients (57.3%) had a diagnosis of psychiatric disorders compared with only 15 of 62 healthy subjects (24.1%) and 9 of the patients with HFS (34.6%). Depressive disorders were more frequent in the CD and BPS groups than in healthy controls, whereas the frequency of anxiety disorders, OCDs or adjustment disorders approached that of healthy subjects. No difference was found in the frequency of any specific psychiatric disorder in patients with LD and arm dystonia and healthy controls. In 35 of 51 patients who had psychiatric disorders, these started before and in 16 patients after the onset of dystonia. No differences were found in age, dystonia severity, and duration of botulinum toxin treatment between patients with and without psychiatric disturbances. The most common psychiatric features in patients with CD and BPS are depressive disorders.

Entities:  

Mesh:

Year:  2010        PMID: 20108377     DOI: 10.1002/mds.22983

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  57 in total

Review 1.  Dystonia: phenomenology.

Authors:  Mark S LeDoux
Journal:  Parkinsonism Relat Disord       Date:  2012-01       Impact factor: 4.891

Review 2.  Diagnosis and treatment of dystonia.

Authors:  H A Jinnah; Stewart A Factor
Journal:  Neurol Clin       Date:  2015-02       Impact factor: 3.806

Review 3.  Blepharospasm 40 years later.

Authors:  Giovanni Defazio; Mark Hallett; Hyder A Jinnah; Antonella Conte; Alfredo Berardelli
Journal:  Mov Disord       Date:  2017-02-10       Impact factor: 10.338

4.  Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study.

Authors:  Daniela Di Giuda; Giovanni Camardese; Anna Rita Bentivoglio; Fabrizio Cocciolillo; Arianna Guidubaldi; Lorella Pucci; Isabella Bruno; Luigi Janiri; Alessandro Giordano; Alfonso Fasano
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-09-14       Impact factor: 9.236

5.  [Botulinum toxin therapy for spasmodic torticollis: medical and non-medical adjunct treatment].

Authors:  B Leplow; M Böttcher; R Schönfeld
Journal:  Nervenarzt       Date:  2013-04       Impact factor: 1.214

Review 6.  The effectiveness of physiotherapy for cervical dystonia: a systematic literature review.

Authors:  Joke De Pauw; Kevin Van der Velden; Jill Meirte; Ulrike Van Daele; Steven Truijen; Patrick Cras; Rudy Mercelis; Willem De Hertogh
Journal:  J Neurol       Date:  2014-01-12       Impact factor: 4.849

7.  Psychiatric disorders in idiopathic-isolated focal dystonia.

Authors:  Alexander Lehn; George Mellick; Richard Boyle
Journal:  J Neurol       Date:  2014-01-22       Impact factor: 4.849

8.  Motor and non-motor symptoms in blepharospasm: clinical and pathophysiological implications.

Authors:  Gina Ferrazzano; Isabella Berardelli; Antonella Conte; Viola Baione; Cristina Concolato; Daniele Belvisi; Giovanni Fabbrini; Giovanni Defazio; Alfredo Berardelli
Journal:  J Neurol       Date:  2019-07-29       Impact factor: 4.849

9.  Evaluation of anxiety and depression scales and quality of LIFE in cervical dystonia patients on botulinum toxin therapy and their relatives.

Authors:  Dursun Ceylan; Sevda Erer; Mehmet Zarifoğlu; Nevin Türkeş; Güven Özkaya
Journal:  Neurol Sci       Date:  2019-01-18       Impact factor: 3.307

10.  Dystonia: Five new things.

Authors:  Brian D Berman; H A Jinnah
Journal:  Neurol Clin Pract       Date:  2015-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.